Lupus Erythematosus Panniculitis

This is a specific type of panniculitis linked to lupus, an autoimmune disease. It causes deep lumps under the skin, often on the face, arms, or scalp. It's usually a long-term condition.

Condition

What people with Lupus Erythematosus Panniculitis report

Every report comes from a Lived member, sent anonymously.

Have you tried Hydroxychloroquine for Lupus Erythematosus Panniculitis?

NameHow it went

About Lupus Erythematosus Panniculitis

What It Is

Lupus erythematosus panniculitis, also called lupus panniculitis or lupus profundus, is a rare form of cutaneous (skin) lupus in which inflammation targets the layer of fat beneath the skin. It causes firm lumps (nodules) or thickened patches that can be tender and may have red or discolored skin over them. They most often appear on the face, upper arms, shoulders, trunk, breasts and buttocks. The lumps tend to come and go over months or years. As a lump settles, the inflamed fat can be lost, leaving a dent or sunken area in the skin, a change called lipoatrophy. Although the condition is not usually dangerous in itself, pain, open sores and these lasting changes in appearance, especially on the face, can weigh heavily on daily life. It can occur on its own, alongside discoid lupus (a scarring rash of the skin surface, present in roughly a fifth to a third of people with this condition), or as one feature of systemic lupus erythematosus (SLE), the form of lupus that can affect joints, kidneys and other organs.

Causes & Risk Factors

Lupus is an autoimmune disease, meaning the immune system attacks the body's own tissues. In this form, immune cells gather in the fat layer and inflame it and its small blood vessels, which leads to scarring and loss of fat. Why lupus targets the fat in some people and the skin surface or internal organs in others is not known. It is most common in women, usually in early to middle adulthood, but it can affect men and children. Injury to the skin, including injections and surgery, has been linked to new lesions or worsening of existing ones in some people. Most people have no identifiable trigger.

How It's Diagnosed

A dermatologist examines the lumps and asks how long they have been present, whether they have come and gone, and about symptoms elsewhere in the body. Because the inflammation sits deep under the skin, the key test is a biopsy that removes a sample deep enough to include fat. Under the microscope, the pattern of inflammation helps confirm lupus and separate it from look-alikes. The most important look-alike is a rare type of lymphoma (subcutaneous panniculitis-like T-cell lymphoma) that can appear in the same places and can look very similar even on biopsy. If the diagnosis is uncertain or lesions do not respond to treatment, further tests on the tissue that check whether the immune cells in it are cancerous, or repeat biopsies, may be needed. Blood and urine tests check for systemic lupus. Antinuclear antibodies (ANA), a common lupus screening test, are often negative when the disease affects only the skin, so a negative result does not rule this condition out. A positive result, especially with antibodies against the body's own genetic material (anti-double-stranded DNA), raises the question of SLE. This condition is often recognized late, particularly when there is no other lupus. Delayed diagnosis has been linked to more permanent fat loss, which is one reason a persistent, unexplained deep lump deserves an assessment.

Treatment Options

Treatment aims to calm active inflammation, prevent new lumps and limit permanent dents and scarring. It cannot reverse fat that has already been lost. There are no randomized trials specific to this condition, so recommendations come from case series and experience with other forms of skin lupus. Hydroxychloroquine (Plaquenil), an antimalarial medicine that dampens lupus activity, is the usual first choice. It works gradually and is generally taken long term. Its main trade-off is a small risk of damage to the retina at the back of the eye that grows with dose and years of use, so a baseline eye exam and regular screening exams are part of treatment. Corticosteroid creams can help when the surface skin is also affected, and a short course of oral steroids such as prednisone may be used to bring a severe flare under control while slower medicines take effect. When hydroxychloroquine alone is not enough, other medicines may be added. These include immunosuppressants such as mycophenolate mofetil (CellCept), methotrexate or azathioprine, as well as dapsone (an antibiotic with anti-inflammatory effects), thalidomide (a medicine that modifies immune activity) or biologic drugs such as rituximab. Mycophenolate is often combined with hydroxychloroquine. Immunosuppressants reduce the body's ability to fight infections, and several of these medicines, including mycophenolate, methotrexate and thalidomide, can cause pregnancy loss or birth defects, so pregnancy planning and reliable contraception are part of the decision. Anifrolumab (Saphnelo), an infusion approved for systemic lupus, has helped in a small number of reported hard-to-treat cases. Steroid injections directly into the lumps, which work well for some skin conditions, appear less helpful here and may deepen the dents. Fillers or fat grafts can improve sunken areas once the disease has been quiet for some time, but injury to the skin can stir up new inflammation, so timing is best decided with the dermatologist.

What to Expect

Lupus erythematosus panniculitis usually follows a long, relapsing course. Lumps may be active for weeks to months, then settle, and new ones can appear later, sometimes when treatment is reduced. Most people improve with treatment, though it can take months to find a regimen that controls new lesions, and dents left behind generally remain. Some lesions develop calcium deposits under the skin (calcinosis), which feel hard and can be painful, and some break down into open sores that heal slowly. Changes in appearance, particularly on the face, upper arms or breasts, can affect confidence and social life. Talking about these effects with the care team is part of care, and support can include counseling and, later, cosmetic repair. Follow-up usually involves regular dermatology visits, eye exams while taking hydroxychloroquine and blood tests for people on immunosuppressants. Because systemic lupus can be present at diagnosis or appear later, ongoing checks for joint pain, fatigue, kidney changes or other lupus symptoms are worthwhile. In people with systemic lupus, care is often shared with a rheumatologist.

When to Seek Help

Arrange a dermatology assessment for a firm or tender lump under the skin that lasts for weeks, keeps coming back or leaves a dent, especially if you already have lupus. Earlier treatment may limit permanent fat loss. Contact your care team if lesions keep growing, spreading or breaking open despite treatment, since this may call for a change in treatment or another biopsy. Report new joint pain, swelling in the legs or face (which can signal kidney involvement), or other new symptoms that could point to systemic lupus, and any change in vision while taking hydroxychloroquine. People taking immunosuppressants should contact the care team promptly about fever or signs of infection.

Questions to Ask Your Doctor

  1. 1.Is a deep biopsy needed to confirm this, and how sure are we that it is lupus rather than another cause such as lymphoma?
  2. 2.Do I have signs of systemic lupus, and how will we check for it over time?
  3. 3.What can treatment realistically achieve for the lumps and the dents they leave, and how long before we know whether it is working?
  4. 4.How will my eyes and blood be monitored on these medicines, and how do they affect plans for pregnancy?
  5. 5.When would it be reasonable to consider fillers or fat grafting for areas of fat loss?

Last reviewed • Oct 2026

Educational content, not medical advice.